A detailed history of South State Corp transactions in United Therapeutics Corp stock. As of the latest transaction made, South State Corp holds 1 shares of UTHR stock, worth $466. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1
Previous 2 50.0%
Holding current value
$466
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 05, 2025

SELL
$274.7 - $438.75 $274 - $438
-1 Reduced 50.0%
1 $0
Q2 2025

Aug 06, 2025

SELL
$276.47 - $328.4 $1,105 - $1,313
-4 Reduced 66.67%
2 $0
Q1 2025

May 12, 2025

BUY
$304.42 - $380.78 $1,826 - $2,284
6 New
6 $1,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $21.2B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track South State Corp Portfolio

Follow South State Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.